DE69833118D1 - Immunoassay zum bestimmen von bnp - Google Patents

Immunoassay zum bestimmen von bnp

Info

Publication number
DE69833118D1
DE69833118D1 DE69833118T DE69833118T DE69833118D1 DE 69833118 D1 DE69833118 D1 DE 69833118D1 DE 69833118 T DE69833118 T DE 69833118T DE 69833118 T DE69833118 T DE 69833118T DE 69833118 D1 DE69833118 D1 DE 69833118D1
Authority
DE
Germany
Prior art keywords
bnp
immunoassay
mammalian
gamma
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69833118T
Other languages
English (en)
Other versions
DE69833118T2 (de
Inventor
Hidehisa Asada
Santaun-Oyashiki Shimizu
Kazuaki Endo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17152093&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69833118(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of DE69833118D1 publication Critical patent/DE69833118D1/de
Application granted granted Critical
Publication of DE69833118T2 publication Critical patent/DE69833118T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69833118T 1997-09-11 1998-09-10 Immunoassay zum bestimmen von bnp Expired - Lifetime DE69833118T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP24668497 1997-09-11
JP24668497 1997-09-11
PCT/JP1998/004063 WO1999013331A1 (fr) 1997-09-11 1998-09-10 Procede de dosage immunologique pour bnp

Publications (2)

Publication Number Publication Date
DE69833118D1 true DE69833118D1 (de) 2006-03-30
DE69833118T2 DE69833118T2 (de) 2006-08-31

Family

ID=17152093

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69833118T Expired - Lifetime DE69833118T2 (de) 1997-09-11 1998-09-10 Immunoassay zum bestimmen von bnp

Country Status (13)

Country Link
US (1) US6828107B2 (de)
EP (1) EP1016867B1 (de)
JP (1) JP3516655B2 (de)
KR (1) KR100563358B1 (de)
CN (1) CN1161609C (de)
AT (1) ATE315228T1 (de)
AU (1) AU731858B2 (de)
CA (1) CA2304263C (de)
DE (1) DE69833118T2 (de)
DK (1) DK1016867T3 (de)
ES (1) ES2256952T3 (de)
NO (1) NO325020B1 (de)
WO (1) WO1999013331A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7632647B2 (en) * 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
US20030219734A1 (en) * 2001-04-13 2003-11-27 Biosite Incorporated Polypeptides related to natriuretic peptides and methods of their identification and use
US7524635B2 (en) * 2003-04-17 2009-04-28 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof
US20040176914A1 (en) * 2001-04-13 2004-09-09 Biosite Incorporated Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential
WO2003016910A1 (en) * 2001-08-20 2003-02-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20030199000A1 (en) * 2001-08-20 2003-10-23 Valkirs Gunars E. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040219509A1 (en) * 2001-08-20 2004-11-04 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040209307A1 (en) * 2001-08-20 2004-10-21 Biosite Incorporated Diagnostic markers of stroke and cerebral injury and methods of use thereof
US7608406B2 (en) * 2001-08-20 2009-10-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
JP3691803B2 (ja) * 2002-03-14 2005-09-07 三洋化成工業株式会社 血液中の心不全マーカー定量方法
AUPS169202A0 (en) * 2002-04-11 2002-05-16 Goetze, Jens Peter Neuropeptide assay
EP3072978B1 (de) 2002-05-09 2018-07-11 The Brigham and Women's Hospital, Inc. 1l1rl-1 als ein marker kardiovaskulärer krankheiten
FR2843396B1 (fr) * 2002-08-07 2005-04-15 Bio Rad Pasteur Anticorps specifiques pour le diagnostic de l'insuffisance cardiaque
US7135329B2 (en) * 2002-11-18 2006-11-14 Princeton Biomeditech Corporation Immunoassay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients
US7109023B2 (en) * 2002-11-18 2006-09-19 Princeton Biomeditech Corporation Immunossay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients
PT1638443E (pt) 2003-06-20 2011-01-25 Mayo Foundation Isoformas de péptido natriurético cerebral
JP2007525213A (ja) * 2004-01-27 2007-09-06 コンピュゲン ユーエスエイ，インク． 新規の脳性ナトリウム利尿ペプチドの変異体及びその利用方法
US20080182299A1 (en) * 2004-01-27 2008-07-31 Compugent Ltd. Novel brain natriuretic peptide variants and methods of use thereof
EP1756583B1 (de) * 2004-03-19 2010-10-27 Biomedica Medizinprodukte GmbH & Co KG Prognoseverfahren für kongestives herzversagen
AT500800B1 (de) * 2004-09-08 2008-07-15 Biomedica Medizinprodukte Gmbh Verfahren zur bestimmung von probnp
WO2006031583A2 (en) * 2004-09-09 2006-03-23 Biosite Incorporated Methods and compositions for measuring canine bnp and uses thereof
US7731965B2 (en) * 2005-02-17 2010-06-08 Abbott Lab Human ring specific BNP antibodies
US20070207152A1 (en) 2005-11-09 2007-09-06 Brophy Susan E Human BNP immunospecific antibodies
US7939069B2 (en) 2005-11-09 2011-05-10 Abbott Laboratories Human BNP immunospecific antibodies
ES2351623T3 (es) 2006-04-24 2011-02-08 Critical Care Diagnostics, Inc. Predicción de la mortalidad y detección de una enfermedad grave.
PT2021796E (pt) * 2006-05-01 2012-04-19 Critical Care Diagnostics Inc Diagnóstico de doença cardiovascular
CN101501067B (zh) 2006-08-08 2013-01-16 梅约医学教育与研究基金会 利尿和利尿钠的多肽
US20080064045A1 (en) 2006-09-07 2008-03-13 Huaiqin Wu Biomarker fragments for the detection of human BNP
US20080108147A1 (en) * 2006-11-03 2008-05-08 Tie Wei Reduction of non-specific binding in immunoassays
WO2008095052A2 (en) 2007-01-30 2008-08-07 Loma Vista Medical, Inc., Biological navigation device
AT504942B1 (de) 2007-03-07 2009-08-15 Biomedica Medizinprodukte Gmbh Verfahren zur bestimmung von probnp
FI20075251A0 (fi) 2007-04-13 2007-04-13 Hytest Oy Immunomääritys epästabiilien antigeenien määrittämiseksi
US20080280377A1 (en) * 2007-05-08 2008-11-13 Abbott Laboratories Human b-type natriuretic peptide assay having reduced cross-reactivity with other peptide forms
US8357656B2 (en) * 2007-09-15 2013-01-22 Mayo Foundation For Medical Education And Research Natriuretic peptide receptor-C agonists
WO2009086126A2 (en) * 2007-12-21 2009-07-09 Mayo Foundation For Medical Education And Research Natriuretic polypeptides
DK2827152T3 (en) 2008-04-18 2016-09-12 Critical Care Diagnostics Inc PREDICTION OF RISK OF MAJOR ADVERSE HEART EVENTS
US9186488B2 (en) 2008-06-02 2015-11-17 Loma Vista Medical, Inc. Method of making inflatable medical devices
CN102334031B (zh) * 2008-12-08 2014-10-08 美艾利尔圣地亚哥有限公司 组合的尿钠肽检测
CN101923090A (zh) * 2009-06-10 2010-12-22 中国科学院电子学研究所 固定人体脑钠肽的光学敏感膜的制备方法
EP3552655B1 (de) 2010-07-13 2020-12-23 Loma Vista Medical, Inc. Aufblasbare medizinische vorrichtungen
AU2011285694B2 (en) 2010-08-04 2014-12-18 Idexx Laboratories, Inc. Detection of degradation products of canine NT-proBNP
US10188436B2 (en) 2010-11-09 2019-01-29 Loma Vista Medical, Inc. Inflatable medical devices
CA2856798A1 (en) 2011-05-31 2012-12-06 Idexx Laboratories, Inc. Detection of degradation products of feline nt-probnp
WO2013032784A1 (en) 2011-08-30 2013-03-07 Mayo Foundation For Medical Education And Research Natriuretic polypeptides
US9611305B2 (en) 2012-01-06 2017-04-04 Mayo Foundation For Medical Education And Research Treating cardiovascular or renal diseases
CN104737170A (zh) 2012-08-21 2015-06-24 重症监护诊断股份有限公司 多标记风险分层
CN112710852B (zh) * 2021-03-26 2021-08-03 上海美迪西生物医药股份有限公司 一种gnp多肽的检测试剂盒及检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2676114B2 (ja) * 1990-04-16 1997-11-12 塩野義製薬株式会社 ｈＢＮＰを認識するモノクローナル抗体および該抗体を用いるｈＢＮＰの免疫測定法
GB9211686D0 (en) * 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds

Also Published As

Publication number Publication date
EP1016867A4 (de) 2004-11-17
CA2304263C (en) 2008-07-29
NO20001273D0 (no) 2000-03-10
JP3516655B2 (ja) 2004-04-05
CN1161609C (zh) 2004-08-11
CN1278919A (zh) 2001-01-03
DK1016867T3 (da) 2006-05-22
EP1016867B1 (de) 2006-01-04
KR100563358B1 (ko) 2006-03-22
US20030157596A1 (en) 2003-08-21
AU731858B2 (en) 2001-04-05
AU9001098A (en) 1999-03-29
US6828107B2 (en) 2004-12-07
NO325020B1 (no) 2008-01-14
EP1016867A1 (de) 2000-07-05
WO1999013331A1 (fr) 1999-03-18
KR20010023853A (ko) 2001-03-26
ATE315228T1 (de) 2006-02-15
DE69833118T2 (de) 2006-08-31
ES2256952T3 (es) 2006-07-16
NO20001273L (no) 2000-05-10
CA2304263A1 (en) 1999-03-18

Similar Documents

Publication Publication Date Title
DE69833118D1 (de) Immunoassay zum bestimmen von bnp
DE59409947D1 (de) Verringerung des Hook-Effekts in Immuntests mit teilchenförmigem Trägermaterial
FI954029A (fi) Kemiluminesoiva reagenssi ja analyysimenetelmä, jossa käytetään substituoitua asetanilidia valon muodostukseen
EP0113075A3 (de) Tragbares Immunoassay-Reaktionssystem, Verfahren zur Diagnose durch eine Immunbestimmung und Sonde oder Träger zur Durchführung des Verfahrens
ES2194139T3 (es) Aumento de la sensibilidad en la determinacion inmunoquimica de un analito.
DE3480494D1 (en) Method and reagent for use in the assay of pivka-ii
ATE254286T1 (de) Zwei-inkubations mit markiertem antigen verwendenes immunoassay
EP0829723A3 (de) Homogene Nachweisverfahren zur Bestimmung von Subpopulationen eines Analyten
ES2023868B3 (es) Procedimiento de determinacion inmunometrico
ATE153134T1 (de) Immunoassayverfahren unter anwendung photothermischer strahlablenkungsspektroskopie
AU657719B2 (en) Methods for determination of an analyte
DE59109139D1 (de) Immunologischer Nachweis von Metolachlor
DE59606685D1 (de) Kompetitiver Immuntest unter Verwendung komplexierter Analytderivate
DE69930843D1 (de) Verfahren zum bestimmen von autoantikörpern
DE69533904D1 (de) Chemische Modifikation von Antikörpern und Antigenen
KR860007545A (ko) 인체 프로릴 4-히드록시라아제의 정량 방법
EP0757250A4 (de) Verfahren zum testen eines asialoglycoproteinrezeptors und testreagenz dafür
DE68919521D1 (de) Immuntest zum Nachweis von alpha-Haloacetamiden.
ATE260936T1 (de) 5-hydroxytryptophol (5-htol) derivate, antikörper,immunoassays und detektion von kürzfristigem alkoholkonsum
JPS5386014A (en) Quantitative analysis of antigen and antibody
AU7943091A (en) Immunological detection methods

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings